QMENTA
About QMENTA
QMENTA is a healthcare AI company specializing in an advanced medical image analysis and visualization platform designed to enhance the diagnosis, treatment, and prognosis of patients with brain diseases. The platform offers a secure, cloud-based data management engine that integrates patented, AI-powered analytical algorithms alongside a marketplace of partnered algorithms. This comprehensive system allows physicians and researchers to efficiently collect, process, and derive high-quality, objective insights from large-scale brain images and related clinical data, aiming to reduce costs and accelerate workflows in clinical trials, research, and routine care.
The QMENTA Imaging Hub provides an all-in-one solution, incorporating an Imaging Cloud for secure PACS connection, a Smart Uploader with automated de-identification and quality checks, over 50 cutting-edge AI Imaging Biomarkers, a Central Review platform, and an Imaging Management System. This integrated approach supports multi-modal imaging data, including MRI, PET, CT, OCT, and EEG, and is fully compliant with regulatory standards such as FDA 21 CFR Part 11 & 820, Annex 11, GDPR, IEC 62304, ISO 13485:2016, and HIPAA. QMENTA’s expertise is deeply rooted in Central Nervous System (CNS) diseases, offering specialized tools for conditions like Multiple Sclerosis, Alzheimer’s Disease, Neuro-Oncology (e.g., tumor segmentation, RANO assessment), and Neuropsychiatric diseases, thereby empowering neurological evaluations with increased confidence and accuracy.
Focus Areas
Business Intelligence
| Key Investors | Intelectium Business Acceleration, Boutique Venture Partners, Flashpoint Venture Capital Group, SineWave Ventures, Horizon 2020, Capital Cell, Wayra, Neurolaunch, Walter Gilbert, Daniel Oliver, PB Investment Partners |
| Partnerships | Alzamend Neuro, Massachusetts General Hospital, Vanderbilt University Medical Center, ICTUSnet |
| Acquisitions | None |
| Technology | Cloud-native, AI-powered analytical algorithms, QMENTA Imaging Hub (Smart Uploader, Imaging Cloud, AI Imaging Biomarkers, Central Review, Imaging Management System), API for integration |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
For physicians, QMENTA stands out by significantly improving diagnosis confidence and accuracy through unique, quantifiable insights into the brain, highlighting tissue changes in 3D and color. The platform enables diagnostic speed by automating cumbersome manual analysis, saving hours of work, and aids in treatment decision-making by providing objective, quantitative data to reduce subjectivity and delays. Its easy-to-use neuroimaging software simplifies data management and AI biomarker application. Physicians gain access to an extensive curated neuroimaging library of over 10 million scans and benefit from full regulatory compliance (FDA 510(k) cleared, HIPAA, GDPR) and built-in security. The cloud-based nature facilitates seamless remote collaboration, and world-class expert support is readily available.
QMENTA's platform is highly integrative, notably through its Software Development Kit (SDK), which allows developers to easily plug in, validate, deploy, and market their own AI tools and applications, supporting Docker containers. They have established partnerships with companies like mediaire (mdbrain algorithm), Imaging Biometrics (IB Neuro, IB Delta T1 Maps, IB Diffusion, IB DCE), Imosphere (Atmolytics for healthcare data management), and Quantib (stroke decision support system). The platform is designed to integrate legally marketed third-party applications for clinical use and offers secure cloud PACS connectivity.
What the Web Says
QMENTA is a Medical Imaging AI tech company that provides cloud-native software solutions for imaging professionals and clinical trials, particularly in neuroimaging. The platform is designed to streamline imaging workflows, offer AI-powered analysis, and ensure regulatory compliance. Reviews generally highlight its advanced capabilities for managing and analyzing medical images, especially for brain MRI, and its focus on neuroscience research and clinical trials.
Overall: PositiveStrengths
- Cloud-based platform, reducing server space and enabling remote access and collaboration.
- Advanced AI-powered image analysis and enhancement, improving diagnostic accuracy and quality assurance.
- Comprehensive solution for managing imaging workflows, including PACS Cloud, Smart Uploader, AI Imaging Biomarkers, Central Review, and Imaging EDC.
- Strong focus on regulatory compliance (FDA 510(k)-cleared, FDA 21 CFR Part 11, HIPAA, GDPR, ISO 13485).
- Vendor-neutral across major DICOM systems (GE HealthCare, Siemens Healthineers, Philips, Canon).
- Automated reporting features minimize radiologist workload and potential errors.
Limitations
- Limited number of reviews available on platforms like G2 and Capterra, making it difficult to get a broad perspective.
- Cloud-based solution requires setting up specific ports and authorization, which can involve paperwork.
- May have limited features compared to full RIS/PACS systems, and no cloud storage for some specific offerings.
- Implementation can be complex, with high upfront costs and extensive training required for fully integrated healthcare IT solutions (though this might refer to broader RIS/PACS systems rather than QMENTA specifically).
Based on reviews from: G2, ITQlick, Capterra, SourceForge, Reddit
Last updated: 2026-07-18
Videos
News, demos, and interviews about QMENTA.
Videos load interactively. If none appear, search YouTube for QMENTA →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded QMENTA.
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]